Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 7, 2023 – 7.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic...